does KAPA have active public offering?

**Kairos Pharma (KAPA) does not currently have an active public offering.** Here's the analysis to support this conclusion: 1. **Closing of Initial Public Offering**: Kairos Pharma closed its initial public offering (IPO) on September 17, 2024. This indicates that the company has already completed its IPO and is not in the process of a new public offering. 2. **No Recent Announcements**: There have been no recent announcements or filings indicating that Kairos Pharma is planning a new public offering. The last news article related to the IPO was dated September 17, 2024. 3. **Stock Performance**: The stock's performance on its first day of trading and in the subsequent days does not necessarily indicate an ongoing public offering. The stock's price fluctuated, but this is typical for newly listed companies and does not imply an ongoing public sale of shares. 4. **Focus on Clinical Trials**: The company's focus is on advancing its clinical trials, particularly for its lead product candidate ENV 105, rather than on public financing activities. In conclusion, Kairos Pharma has not initiated a new public offering, and it is not actively seeking public financing at this time. The company is focused on the development of its product pipeline and the continuation of its clinical trials.